Clinical Trials Browser

Phase 1 × Interventional × silmitasertib × Clear all

NCT03897036 2025-05-20

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Phase 1 Completed

25 enrolled 9 charts

Carcinoma, Basal Cell

NCT01199718 2011-06-15

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Plasmacytoma